Solid lipid nanoparticles as insulin inhalation carriers for enhanced pulmonary delivery

Journal of Biomedical Nanotechnology

Volumn 5, Issue 1, 2009, Pages 84-92

  Bi, Ru ^a   Shao, Wei ^a   Wang, Qun ^b   Zhang, Na ^a  

^a SHANDONG UNIVERSITY   (China)

^b University of Kansas   (United States)

Author keywords

Dry powder inhalation (DPI); Insulin (Ins); Intratracheal instillation; Pulmonary delivery; Solid lipid nanoparticles (SLNs); Spray freeze drying (SFD)

Indexed keywords

DRY POWDER INHALATION (DPI); INTRATRACHEAL INSTILLATION; PULMONARY DELIVERY; SOLID LIPID NANOPARTICLES (SLNS); SPRAY FREEZE DRYING (SFD);

AMINES; BIOCHEMISTRY; DEWATERING; DRUG INTERACTIONS; ELECTRIC IMPEDANCE; INSULIN; NANOPARTICLES; PACKET NETWORKS; POWDERS; ROTATING MACHINERY; SHOCK ABSORBERS; SUGAR (SUCROSE);

CURING;

INSULIN; POLOXAMER; SOLID LIPID NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG BIOAVAILABILITY; DRUG EFFECT; DRUG FORMULATION; DRUG INSTILLATION; DRUG STABILITY; DRY POWDER; FREEZE DRYING; HYPOGLYCEMIA; INHALATION; LIPOSOMAL DELIVERY; MALE; NONHUMAN; RAT; SUSTAINED DRUG RELEASE;

ADMINISTRATION, INHALATION; ANIMALS; BLOOD GLUCOSE; CRYSTALLIZATION; DIABETES MELLITUS, EXPERIMENTAL; DRUG COMPOUNDING; INSULIN; LIPIDS; MALE; MATERIALS TESTING; NANOMEDICINE; NANOPARTICLES; PARTICLE SIZE; POWDERS; RATS; RATS, SPRAGUE-DAWLEY; SURFACE PROPERTIES;

EID: 67649764422     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2009.036     Document Type: Article

References (39)

1. V. V. Ranade, Inhalation therapy: New delivery systems. Am. J. Ther. 8, 367 (2001).
2. T. R. Kumar, K. Soppimath, and S. K. Nachaegari, Novel delivery technologies for protein and peptide therapeutics. Curr. Pharm. Biotechnol. 7, 261 (2006).
3. R. U. Agu, M. I. Ugwoke, M. Armand, R. Kinget, and N. Verbeke, The lung as a route for systemic delivery of therapeutic proteins and peptides. Respir. Res. 2, 198 (2001).
4. C. Bosquillon, C. Lombry, V. Préat, and R. Vanbever, Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance. J. Control. Release 70, 329 (2001).
5. F. W. Wigley, J. H. Londono, S. H. Wood, J. C. Shipp, and R. H. Waldman, Insulin across respiratory mucosae by aerosol delivery. Diabetes. 20, 552 (1971).
6. J. S. Patton, J. G. Bukar, and M. A. Eldon, Clinical pharmacokinetics and pharmacodynamics of inhaled insulin. Clin. Pharmacokinet. 43, 781 (2004).
7. http://www.exubera.com/content/con-index.jsp?setShowOn=../content/ con-index.jsp&setShowHighlightOn=../content/con-index.jsp.
8. J. G. Hardy and T. S. Chadwick, Sustained release drug delivery to the lungs: An option for the future. Clin. Pharmacokinet. 39, 1 (2000).
9. W. Mehnert and K. Mader, Solid lipid nanoparticles. Production, characterization and applications. Adv. Drug Deliv. Rev. 47, 165 (2001).
10. T. Lian and R. J. Y. Ho, Trends and developments in liposome drug delivery systems. J. Pharm. Sci. 90, 667 (2001).
11. J. Kreuter, Nanoparticle-based drug delivery systems. J. Control. Release 16, 169 (1991).
12. M. C. Jones and J. C. Leroux, Polymeric micelles - a new generation of colloidal drug carriers. Eur. J. Pharm. Biopharm. 48, 101 (1999).
13. R. Cortesi, E. Esposito, G. Luca, and C. Nastruzzi, Production of lipospheres as carriers for bioactive compounds. Biomaterials 23, 2283 (2002).
14. S. Jaspart, G. Piel, L. Delattre, and B. Evrard, Solid lipid microparticles: Formulation, preparation, characterisation, drug release and applications. Expert Opin. Drug Deliv. 2, 75 (2005).
15. M. Trotta, R. Cavalli, M. E. Carlotti, L. Battaglia, and F. Debernardi, Solid lipid microparticles carrying insulin formed by solvent-in-water emulsion-dilusion technique. Int. J. Pharm. 288, 281 (2005).
16. V. Sanna, N. Kirschvink, P. Gustin, E. Gavini, I. Roland, L. Delattre, and B. Evrard, Preparation and in vivo toxicity study of solid lipid microparticles as carrier for pulmonary administration. AAPS Pharm. Sci. Tech. 5, e27 (2004).
17. A. Lippacher, Entwicklung und Charakterisierung von flüssigen und halbfesten SLN-Dispersionen zur topischen Applikation. Ph.D. thesis, Free University of Berlin (2000).
18. J. K. Varia, S. S. Dodiya, and K. K. Sawant, Cyclosporine loaded solid lipid nanoparticles: Optimization of formulation, process variable and characterization. Curr. Drug. Deliv. 5, 64 (2008).
19. Y. F. Maa and P. A. Nguyen, Method of spray freeze drying proteins for pharmaceutical administration. US Patent 6284282 (2001), September 4.
20. D. J. van Drooge, W. L. Hinrichs, B. H. Dickhoff, M. N. Elli, M. R. Visser, G. S. Zijlstra, and H. W. Frijlink, Spray freeze drying to produce a stable Delta(9)-tetrahydrocannabinol containing inulin-based solid dispersion powder suitable for inhalation. Eur. J. Pharm. Sci. 26, 231 (2005).
21. J. D. Engstrom, D. T. Simpson, C. Cloonan, E. S. Lai, and R. O. Williams, 3rd., G. Barrie Kitto, and K. P. Johnston, Stable high surface area lactate dehydrogenase particles produced by spray freezing into liquid nitrogen. Eur. J. Pharm. Biopharm. 65, 163 (2007).
22. N. Zhang, Q. N. Ping, G. H. Huang, and W. F. Xu, Investigation of lectin-modified insulin liposomes as carriers for oral administration. Int. J. Pharm. 294, 247 (2005).
23. European Pharmacopeia. Suppl. 5.1. Section 2.9.18-preparations for inhalation: aerodynamic assessment of fine particles. European Pharmacopeia, 5th edn., Council of Europe, Strasbourg, France (2005), pp. 2799-2811.
24. S. P. Shah and A. Misra, Liposomal amikacin dry powder inhaler: Effect of fines on in vitro performance. AAPS Pharm. Sci. Tech. 5, 1 (2004).
25. A. Cilek, N. Celebi, F. Tirnaksiz, and A. Tay, A lecithin- based microemulsion of rh-insulin with aprotinin for oral administration: Investigation of hypoglycemic effects in non-diabetic and STZ-induced diabetic rats. Int. J. Pharm. 298, 176 (2005).
26. M. Jurima-Romet and P. N. Shek, Lung uptake of liposome- entrapped glutathione after intratracheal administration. J. Pharm. Pharmacol. 43, 6 (1991).
27. M. A. Radwan and H. Y. Aboul-Enein, The effect of oral absorption enhancers on the in vivo performance of insulin- loaded poly(ethylcyanoacrylate) nanospheres in diabetic rats. J. Microencapsul. 19, 225 (2002).
28. E. Zimmerman, R. H. Müller, and K. Mäder, Influence of different parameters on reconstitution of lyophilized SLN. Int. J. Pharm. 196, 211 (2000).
29. D. Quitannar-Guerrero, A. Ganem-Quintanar, E. Alleman, H. Fessi, and E. Doelker, Influence of the stabilizer coating layer on the purification and freeze-drying of poly(D,L-lactic acid) nanoparticles prepared by emulsion-diffusion technique. J. Microencapsulation. 15, 107 (1998).
30. K. Miyajima, Role of saccharides for the freeze-thawing and the freeze-drying of liposome. Adv. Drug Deliv. Rev. 24, 151 (1997).
31. P. Shahgaldian, J. Gualbert, K. Aïssa, and A. W. Coleman, A study of the freeze-drying conditions of calixarene based solid lipid nanoparticles. Eur. J. Pharm. Biopharm. 55, 181 (2003).
32. W. C. Mobley and H. Schreier, Phase transition temperature reduction and glass transformation in dehydroprotected lyophilized liposomes. J. Control. Release 31, 73 (1994).
33. C. Schwarz and W. Mehnert, Freeze-drying of drug-free and drug-loaded solid lipid nanoparicles. Int. J. Pharm. 157, 171 (1997).
34. Y. F. Maa, P. A. Nguyen, T. Sweeney, S. J. Shire, and C. C. Hsu, Protein inhalation powders: Spray drying vs spray freeze drying. Pharm. Res. 16, 249 (1999).
35. J. P. Mitchell, M. W. Nagel, and A. D. Archer, Size analysis of a pressurized metered dose inhaler-delivered suspension formulation by the API Aerosizer time-of-flight aerodynamic particle size analyzer. J. Aerosol. Med. 12, 255 (1999).
36. J. P. Mitchell, M. W. Nagel, K. J. Wiersema, and C. C. Doyle, Aerodynamic particle size analysis of aerosols from pressurized metered- dose inhalers: Comparison of Andersen 8-stage cascade impactor, next generation pharmaceutical impactor, and model 3321 aerodynamic particle sizer aerosol spectrometer. AAPS Pharm. Sci. Tech. 4, E54 (2003).
37. R. Vanbever, J. D. Mintzes, J. Wang, J. Nice, D. Chen, R. Batycky, R. Langer, and D. A. Edwards, Formulation and physical characterization of large porous particles for inhalation. Pharm. Res. 16, 1735 (1999).
38. S. H. Park, J. H. Kwon, S. H. Lim, H. W. Park, and C. W. Kim, Characterization of human insulin microcrystals and their absorption enhancement by protease inhibitors in rat lungs. Int. J. Pharm. 339, 205 (2007).
39. A. Hussain, J. J. Arnold, M. A. Khan, and F. Ahsan, Absorption enhancers in pulmonary protein delivery. J. Control. Release 94, 15 (2004).